Thermo Fisher Eliminates 530 Jobs in H1 2012, Buys Pre-eclampsia Test Firm for up to $7.5M | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific disclosed in its quarterly earnings document that it has eliminated about 530 jobs through the first six months of 2012.

It also disclosed an acquisition for a price of potentially up to $7.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.